Efficacy and safety of pyrotinib in the treatment of HER2-positive liver metastatic advanced breast cancer

BackgroundThis study aimed to evaluate the efficacy and safety of pyrotinib in the treatment of HER2-positive breast cancer patients with and without liver metastasis.MethodsA retrospective analysis was conducted on 91 patients with HER2-positive advanced breast cancer, who were treated with pyrotin...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Yongxia Li, Yong Li, Taolang Li, Mingyuan He, Jianying Chang, Hui Cao, Daiqin Luo, Junyuan Lv, Yunbi Zou, Yuyan Zheng, Li Ran, Feiyue Yang, Li Huang, Xiaoming Cheng
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Frontiers Media S.A. 2025-04-01
Cyfres:	Frontiers in Oncology
Pynciau:	breast cancer pyrotinib HER2-positive liver metastasis efficacy and safety
Mynediad Ar-lein:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1527277/full
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!